AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Alpha 1-proteinase Inhibitor, Human (Systemic).

USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language

| July 28, 2005 | COPYRIGHT 1996 USP DIĀ® and Advice for the PatientĀ® are registered trademarks of USP used under license to Micromedex, Inc. (Hide copyright information)Copyright
 
In the U.S. -- 
     Aralast 
     Prolastin 
 
In Canada -- 
     Prolastin 

Another commonly used name is alpha (1)-antitrypsin.

 
     Alpha (1)-antitrypsin replenisher 
Description 

Alpha (1)-proteinase (AL-fa wun PRO-teen-ayce) inhibitor (alpha (1)-PI) is used to treat emphysema caused by the lack of a certain protein, alpha (1)-antitrypsin, in the body. This medicine replaces the protein when the body does not produce enough by itself.

Alpha (1)-PI is prepared from human blood received from many donors. Each donor's blood is tested for human immunodeficiency virus (HIV) and hepatitis B virus before it is used to prepare this medicine. Also, alpha (1)-PI is treated with heat to reduce further the risk of transmission of virus infections. Other processes are also done to help make the alpha (1)-PI more pure. However, no procedure has been found to be totally effective in removing viruses from blood products.

There have not been any reports of hepatitis developing in any patients receiving alpha (1)-PI. Your …

Related articles from newspapers, magazines, journals, and more
Alpha 1-proteinase Inhibitor, Human (Systemic).(Drug overview)
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language August 1, 2006 700+ words
Alpha 1-proteinase inhibitor, Human (Systemic).
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language January 1, 1997 700+ words
ALPHA-1 PROTEINASE INHIBITOR HUMAN (Intravenous route) - AL-fa 1 PRO-teen-aze...
USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language May 1, 2007 700+ words
Committee for Orphan Medicinal Products public summary of positive opinion...
News wire article from: Chemical Business Newsbase February 24, 2009 700+ words
Aventis Behring receives FDA approval for Zemaira for alpha-1-proteinase...
News wire article from: Asia Africa Intelligence Wire July 10, 2003 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily